Three-Year Parkinson's drug test seeks to calm overactive immune system
NCT ID NCT03790670
Summary
This small, early-stage study tested the safety of giving a drug called Leukine to people with Parkinson's disease for three years. Researchers wanted to see if this drug, which affects the immune system, was safe and tolerable at a lower dose schedule. They also checked if the treatment changed immune cell activity and whether it might improve Parkinson's symptoms like movement and mobility.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.